Building a New Biomedical Ecosystem: Pfizer's Centers for Therapeutic Innovation | Zendy

Patel A C | Zendy; Coyle A J | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Building a New Biomedical Ecosystem: Pfizer's Centers for Therapeutic Innovation

Author(s) -

Patel A C,

Coyle A J

Publication year - 2013

Publication title -

clinical pharmacology and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.941

H-Index - 188

eISSN - 1532-6535

pISSN - 0009-9236

DOI - 10.1038/clpt.2013.89

Subject(s) - general partnership , transparency (behavior) , incentive , clinical pharmacology , business , productivity , knowledge management , management , pharmacology , medicine , political science , economics , computer science , economic growth , finance , law , microeconomics

It is becoming increasingly clear that to significantly enhance research and development productivity and innovation, new external partnerships are essential. Although partnership between academia and industry is not a novel concept, the manner in which such collaborations are designed and implemented has evolved. In 2010, Pfizer took decisive steps to form the Centers for Therapeutic Innovation: a partnership model with academia based on true collaboration, reflected by transparency, shared decision making, and aligned incentives for sustainable innovation. Clinical Pharmacology & Therapeutics (2013); 94 3, 314–316. doi: 10.1038/clpt.2013.89

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research